SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Briefs

Advertisement


Inside Views

Contribute your views! Submit an Inside Views idea to info [at] ip-watch [dot] ch.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Occupy IP: New Economy Businesses Clash With Old

It may be too much, too late for content providers finally trying to tame the internet, and a fresh approach is needed, writes Bruce Berman.




Special Reports

Non-Communicable Diseases Issue Energises Public Health Policymakers Read More >


Latest Comments
  • I deeply apprecite the initiative to combat agains... »
  • 1. Cuál es el problema principal que se plantea en... »

  • For IPW Subscribers
    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    ACTA Negotiators Vow To Mesh With National-Level Rights; Withhold New Text

    Published on 2 July 2010 @ 3:50 pm

    By for Intellectual Property Watch

    LUCERNE, SWITZERLAND – There was progress during the ninth round of negotiations for the Anti-Counterfeiting Trade Agreement (ACTA) this week in Lucerne, negotiators said over the last day, and in their final press communiqué they made promises that “ACTA will not interfere with a signatory’s ability to respect fundamental rights and liberties,” it would be consistent with World Trade Organization agreements and certainly “not hinder the cross-border transit of legitimate generic medicine.”

    But negotiators could not agree to allow the interested public or experts to check how these promises would be phrased, as no new draft ACTA text was released at the meeting’s conclusion yesterday. The final press communiqué is available here.

    “We are regretting this,” Jürg Herren, head of legal services, general law in the Division of Legal & International Affairs of the Swiss Federal Institute of Intellectual Property, said after the meeting, seconded by the EU delegation head Luc Devigne. “We were strongly in favour of publishing it,” said Devigne.

    Yet one delegation had blocked consensus on this, the two Europeans said. As the group had agreed to proceed on consensus, the negotiators all are bound by this, they said. The next meeting of ACTA will take place in the United States, for some a signal that the US is interested in getting ACTA finished quickly.

    Some negotiators said they saw a real acceleration during the last round in Wellington and this Lucerne meeting, and some optimists had expected to come close to the end of the negotiation during the Swiss round. Yamamoto Shinpei, director for intellectual property in the Multilateral Trade System Department of the Japanese Ministry of Economy, Trade and Industry, said finalising ACTA by the end of this year was realistic. While there was still a lot of bracketed text, some sections had been straightened out.

    “There is a consensus that patents should not be covered in the border measures and the criminal enforcement section,” said Devigne. While some countries would be satisfied to limit ACTA to counterfeiting and copyright piracy, the EU’s position was to keep patents in there.

    The scope issue will only be settled at the very end, said Herren. The inclusion of geographical indications or not is “a deal-breaker,” said Jorge Amigo, director general of the Mexican Institute of Industrial Property (IMPI). Mexico, like Switzerland and the EU, favour the inclusion of geographical indications against the Anglo-American countries. In Mexico, there was even a discussion to adapt the existing legislation on appellation of origin to the geographical indications approach, said Amigo.

    Questioned for real steps forward in the still heavily bracketed text, Herren said: “We for example cleared the part on damages a lot.” The chapter now has the various systematic legal approaches covered in a much less complicated manner, he said. For a country like Switzerland, he added, pre-established instead of licence-cost based damages were out of the question. So despite more clarity, all national versions are still in the text, according to information from the negotiators.

    Critics like Knowledge Ecology International have warned especially against an upward harmonisation towards high damages. But when asked if the Swiss with the licence-oriented damage-structure were not afraid of an upward spiral once higher damages were an option in ACTA, Herren said: “Such legislative changes could happen outside of ACTA, too.”

    This might as well be true for three-strikes internet cut-offs for repeated copyright infringement and additional liability – they become only optional in ACTA and they already happen outside ACTA just now. Japan, independent from ACTA, has been discussing the introduction of the Digital Millennium Copyright Act analogue legislation on technological protection measures. These measures also are part of the ACTA.

    ACTA could be used as a reference framework for tightening the measures, critics like Canadian law professor Michael Geist have warned for some time now. European telecommunications operators expressed the same concern recently for their business. “The draft ACTA provisions aim for a minimum set of obligations. A party may implement in its domestic law more extensive protection and enforcement of intellectual property rights,” the telecom operators said in their press release. “Hence, a final ACTA-agreement will not lead to fewer demands for additional measures on national levels, but rather would act as a base for further obligations on ISPs.”

    Nongovernmental organisations, which had talks on Monday with the ACTA delegations, had a fight with the French delegate over the shift of responsibility from public to private actors (see the protocol of the exchange of views here). “It is companies that collect the information” (about users’ behaviour on the internet), one NGO representative said in a heated exchange, according to the NGO report of the talks. “You are encouraging the companies to use that information in ways that, if done by the state, would violate fundamental privacy protections,” he said, adding, “Is that promoting fundamental rights?”

    EU ACTA negotiators in Lucerne told Intellectual Property Watch once more that they stood firmly within the EU aquis communautaire, the existing legal framework of the Union, changes to which are not acceptable under their negotiating mandate. Yet some bracketed proposals of the internet chapter go beyond the acquis, like the request for internet service providers to remove access to internet content expeditiously when they have “reasonable grounds to know that the infringement is occurring.” This would involve ISPs checking for what their users do.

    The NGOs focused on the access to generic drugs also are not satisfied with the commitments of ACTA negotiators to take patents out of the enforcement and criminal sanction chapters. Oxfam, the Berne Declaration and the Aids-Initiative Act Up Paris published a highly critical statement yesterday.

    “The Anti-Counterfeiting Trade Agreement is the latest gift from rich countries to the multinational pharmaceutical industry to limit access to affordable, generic medicines in developing countries,” Rohit Malpani from Oxfam said, according to a press release. “Despite numerous warnings, countries are persisting in their push for new intellectual property rules that will harm public health around the world.”

    Patrick Durisch, Berne Declaration added: “ACTA would in a very undemocratic way contribute to establish a climate of general suspicion and shift enforcement burdens from the private to the public sector, whilst not solving the problem with dangerous fake medicines.”

    Pauline Londeix from Act Up-Paris said, “2010 was supposed to be the year of the universal access to HIV/AIDS treatments. But in 2010, less than 40 percent of people among those who need it urgently have access to life-saving drugs. If concluded, ACTA will hinder access to cheap generic medicines and millions of people will be denied access to life-saving treatment.”

    [Updated:] The Computer and Communications Industry Association said afterward that as the US prepares to celebrate its independence this weekend, ACTA threatens to limit the protection of and extension of our freedoms to the internet world. “Americans and Internet users around the world are facing mounting efforts by governments to expand their control, restrict new models of communication, and deploy sweeping tools to inhibit dynamic Internet activity,” CCIA said in a release.

    There also was support for ACTA [pdf] during the Lucerne meeting. BusinessEurope, the International Intellectual Property Protection Forum of Japan (IIPPF), and the Global Intellectual Property Center (GIPC) of the US Chamber of Commerce welcomed the ACTA negotiation as “the agreement would help ensure the like-minded trading partners to address counterfeiting.” The business organisations also applauded the release of the Wellington draft. The holding back of the new text might not be that welcome even for ACTA fans. [end of update]

    Transparency again could become an issue of public discussion after the decision of Lucerne not to publish a new draft version. Civil society groups wrote in their joint declaration Thursday that they were “outraged” negotiators did not confirm they would release the new ACTA version. Several delegates at the Lucerne meeting said they could not comment on the progress of the negotiations to the press. A US delegate Thursday morning said she was “not allowed to speak,” and no press briefing or availability was announced, which is a departure from international trade negotiations of the past.

    Monika Ermert may be reached at info@ip-watch.ch.

     

    Comments

    1. Shane says:

      ACTA will hinder access to cheap generic medicines and millions of people will be denied access to life-saving treatment? Surely countries around the world have the legal clout to gather together and help third world countries? or is there no desire to help?

    2. Today’s headlines, July 06 says:

      [...] ACTA terms flunk consensus [...]

    3. ACTA-bloggen » Blog Archive » Hemlighetsmakeriet är i full gång igen says:

      [...] princip ingenting, och någon ny inblick i vad som pågår har inte delgivits allmänheten. Enligt IP-Watch så beror detta på att en av förhandlingsparterna satt sig på tvären. I enlighet med den [...]

    4. ACTA-bloggen » Blog Archive » Röstresultatet offentligt, liberaler svek den gemensamma resolutionen says:

      [...] Pauline Londeix från Act Up-Paris [...]


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.